MedChem Products Inc. of Woburn, Mass., announced on Tuesdaythat it completed a public offering of 2.25 million shares ofcommon stock (AMEX:MCH) at $12.50 per share, raising $28.1million. There was no overallotment. MedChem filed theoffering on June 12.

Of the shares sold, 1.75 million shares were sold by thecompany and 500,000 shares were sold by stockholders.Furman Selz Inc. was the underwriter.

MedChem develops, manufactures and markets biomedicalproducts for surgical markets.

(c) 1997 American Health Consultants. All rights reserved.